-
1
-
-
84865041123
-
Stroke and bleeding in atrial fibrillation with chronic kidney disease
-
Olesen JB, Lip GY, Kamper AL, Hommel K, Køber L, Lane DA, Lindhardsen J, Gislason GH, Torp-Pedersen C. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012;367:625-635.
-
(2012)
N Engl J Med.
, vol.367
, pp. 625-635
-
-
Olesen, J.B.1
Lip, G.Y.2
Kamper, A.L.3
Hommel, K.4
Køber, L.5
Lane, D.A.6
Lindhardsen, J.7
Gislason, G.H.8
Torp-Pedersen, C.9
-
2
-
-
84861754446
-
Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists
-
Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics)
-
Poli D, Antonucci E, Zanazzi M, Grifoni E, Testa S, Ageno W, Palareti G. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics). Thromb Haemost. 2012;107:1100-1106.
-
(2012)
Thromb Haemost.
, vol.107
, pp. 1100-1106
-
-
Poli, D.1
Antonucci, E.2
Zanazzi, M.3
Grifoni, E.4
Testa, S.5
Ageno, W.6
Palareti, G.7
-
3
-
-
0141566823
-
Risk factors for incident stroke among patients with end-stage renal disease
-
Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO. Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol. 2003;14:2623-2631.
-
(2003)
J Am Soc Nephrol.
, vol.14
, pp. 2623-2631
-
-
Seliger, S.L.1
Gillen, D.L.2
Tirschwell, D.3
Wasse, H.4
Kestenbaum, B.R.5
Stehman-Breen, C.O.6
-
4
-
-
0025779484
-
Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
-
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
-
(1991)
Stroke
, vol.22
, pp. 983-988
-
-
Wolf, P.A.1
Abbott, R.D.2
Kannel, W.B.3
-
5
-
-
84868569866
-
Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation?
-
Clase CM, Holden RM, Sood MM, Rigatto C, Moist LM, Thomson BK, Mann JF, Zimmerman DL. Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation? Nephrol Dial Transplant. 2012;27:3719-3724.
-
(2012)
Nephrol Dial Transplant.
, vol.27
, pp. 3719-3724
-
-
Clase, C.M.1
Holden, R.M.2
Sood, M.M.3
Rigatto, C.4
Moist, L.M.5
Thomson, B.K.6
Mann, J.F.7
Zimmerman, D.L.8
-
6
-
-
84873419961
-
Atrial fibrillation and risk of stroke in dialysis patients
-
Wetmore JB, Ellerbeck EF, Mahnken JD, Phadnis M, Rigler SK, Mukhopadhyay P, Spertus JA, Zhou X, Hou Q, Shireman TI. Atrial fibrillation and risk of stroke in dialysis patients. Ann Epidemiol. 2013;23:112-118.
-
(2013)
Ann Epidemiol.
, vol.23
, pp. 112-118
-
-
Wetmore, J.B.1
Ellerbeck, E.F.2
Mahnken, J.D.3
Phadnis, M.4
Rigler, S.K.5
Mukhopadhyay, P.6
Spertus, J.A.7
Zhou, X.8
Hou, Q.9
Shireman, T.I.10
-
7
-
-
80052836882
-
A new era for anticoagulation in atrial fibrillation
-
Mega JL. A new era for anticoagulation in atrial fibrillation. N Engl J Med. 2011;365:1052-1054.
-
(2011)
N Engl J Med.
, vol.365
, pp. 1052-1054
-
-
Mega, J.L.1
-
8
-
-
70349908012
-
Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation
-
Chan KE, Lazarus JM, Thadhani R, Hakim RM. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol. 2009;20:2223-2233.
-
(2009)
J Am Soc Nephrol.
, vol.20
, pp. 2223-2233
-
-
Chan, K.E.1
Lazarus, J.M.2
Thadhani, R.3
Hakim, R.M.4
-
9
-
-
65349189718
-
Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients
-
Chan KE, Lazarus JM, Thadhani R, Hakim RM. Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. J Am Soc Nephrol. 2009;20:872-881.
-
(2009)
J Am Soc Nephrol.
, vol.20
, pp. 872-881
-
-
Chan, K.E.1
Lazarus, J.M.2
Thadhani, R.3
Hakim, R.M.4
-
10
-
-
14544283020
-
Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD
-
Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004;15:2857-2867.
-
(2004)
J Am Soc Nephrol.
, vol.15
, pp. 2857-2867
-
-
Reynolds, J.L.1
Joannides, A.J.2
Skepper, J.N.3
McNair, R.4
Schurgers, L.J.5
Proudfoot, D.6
Jahnen-Dechent, W.7
Weissberg, P.L.8
Shanahan, C.M.9
-
11
-
-
84883242493
-
Atrial fibrillation in CKD: Balancing the risks and benefits of anticoagulation
-
Ng KP, Edwards NC, Lip GY, Townend JN, Ferro CJ. Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation. Am J Kidney Dis. 2013;62:615-632.
-
(2013)
Am J Kidney Dis.
, vol.62
, pp. 615-632
-
-
Ng, K.P.1
Edwards, N.C.2
Lip, G.Y.3
Townend, J.N.4
Ferro, C.J.5
-
12
-
-
65249183151
-
Dilemmas in the management of atrial fibrillation in chronic kidney disease
-
Reinecke H, Brand E, Mesters R, Schäbitz WR, Fisher M, Pavenstädt H, Breithardt G. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol. 2009;20:705-711.
-
(2009)
J Am Soc Nephrol.
, vol.20
, pp. 705-711
-
-
Reinecke, H.1
Brand, E.2
Mesters, R.3
Schäbitz, W.R.4
Fisher, M.5
Pavenstädt, H.6
Breithardt, G.7
-
13
-
-
84868223127
-
Anticoagulation for atrial fibrillation in patients on dialysis: Are the benefits worth the risks?
-
Shen JI, Turakhia MP, Winkelmayer WC. Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks? Curr Opin Nephrol Hypertens. 2012;21:600-606.
-
(2012)
Curr Opin Nephrol Hypertens
, vol.21
, pp. 600-606
-
-
Shen, J.I.1
Turakhia, M.P.2
Winkelmayer, W.C.3
-
14
-
-
70350137229
-
The intersection of risk and benefit: Is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis?
-
Sood MM, Komenda P, Sood AR, Rigatto C, Bueti J. The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis? Chest. 2009;136:1128-1133.
-
(2009)
Chest
, vol.136
, pp. 1128-1133
-
-
Sood, M.M.1
Komenda, P.2
Sood, A.R.3
Rigatto, C.4
Bueti, J.5
-
15
-
-
34548509436
-
Atrial fibrillation in haemodialysis patients: Do the guidelines for anticoagulation apply?
-
To AC, Yehia M, Collins JF. Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply? Nephrology (Carlton). 2007;12:441-447.
-
(2007)
Nephrology (Carlton)
, vol.12
, pp. 441-447
-
-
To, A.C.1
Yehia, M.2
Collins, J.F.3
-
16
-
-
80755152863
-
Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation
-
Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011;6:2662-2668.
-
(2011)
Clin J Am Soc Nephrol.
, vol.6
, pp. 2662-2668
-
-
Winkelmayer, W.C.1
Liu, J.2
Setoguchi, S.3
Choudhry, N.K.4
-
17
-
-
77956897768
-
Atrial fibrillation in hemodialysis patients: Clinical features and associations with anticoagulant therapy
-
Wizemann V, Tong L, Satayathum S, Disney A, Akiba T, Fissell RB, Kerr PG, Young EW, Robinson BM. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int. 2010;77:1098-1106.
-
(2010)
Kidney Int.
, vol.77
, pp. 1098-1106
-
-
Wizemann, V.1
Tong, L.2
Satayathum, S.3
Disney, A.4
Akiba, T.5
Fissell, R.B.6
Kerr, P.G.7
Young, E.W.8
Robinson, B.M.9
-
18
-
-
84877579357
-
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Wann LS, Curtis AB, Ellenbogen KA, Estes NA 3rd, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Le Heuzey JY, Kay GN, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:1916-1926.
-
(2013)
Circulation
, vol.127
, pp. 1916-1926
-
-
Anderson, J.L.1
Halperin, J.L.2
Albert, N.M.3
Bozkurt, B.4
Brindis, R.G.5
Curtis, L.H.6
DeMets, D.7
Guyton, R.A.8
Hochman, J.S.9
Kovacs, R.J.10
Ohman, E.M.11
Pressler, S.J.12
Sellke, F.W.13
Shen, W.K.14
Wann, L.S.15
Curtis, A.B.16
Ellenbogen, K.A.17
Estes III, N.A.18
Ezekowitz, M.D.19
Jackman, W.M.20
January, C.T.21
Lowe, J.E.22
Page, R.L.23
Slotwiner, D.J.24
Stevenson, W.G.25
Tracy, C.M.26
Fuster, V.27
Rydén, L.E.28
Cannom, D.S.29
Crijns, H.J.30
Curtis, A.B.31
Ellenbogen, K.A.32
Le Heuzey, J.Y.33
Kay, G.N.34
Olsson, S.B.35
Prystowsky, E.N.36
Tamargo, J.L.37
Wann, S.38
more..
-
19
-
-
77957738116
-
Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
-
Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De CR, De SJ, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12:1360-420.
-
(2010)
Europace
, vol.12
, pp. 1360-1420
-
-
Camm, A.J.1
Kirchhof, P.2
Lip, G.Y.3
Schotten, U.4
Savelieva, I.5
Ernst, S.6
Van Gelder, I.C.7
Al-Attar, N.8
Hindricks, G.9
Prendergast, B.10
Heidbuchel, H.11
Alfieri, O.12
Angelini, A.13
Atar, D.14
Colonna, P.15
De, C.R.16
De, S.J.17
Goette, A.18
Gorenek, B.19
Heldal, M.20
Hohloser, S.H.21
Kolh, P.22
Le Heuzey, J.Y.23
Ponikowski, P.24
Rutten, F.H.25
more..
-
20
-
-
84875508668
-
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association
-
ESC Committee for Practice Guidelines-CPG; Document Reviewers
-
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines-CPG; Document Reviewers. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14:1385-1413.
-
(2012)
Europace
, vol.14
, pp. 1385-1413
-
-
Camm, A.J.1
Lip, G.Y.2
De Caterina, R.3
Savelieva, I.4
Atar, D.5
Hohnloser, S.H.6
Hindricks, G.7
Kirchhof, P.8
-
21
-
-
34248664839
-
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation
-
A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
-
Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e257-e354.
-
(2006)
Circulation
, vol.114
-
-
Fuster, V.1
Ryden, L.E.2
Cannom, D.S.3
Crijns, H.J.4
Curtis, A.B.5
Ellenbogen, K.A.6
Halperin, J.L.7
Le Heuzey, J.Y.8
Kay, G.N.9
Lowe, J.E.10
Olsson, S.B.11
Prystowsky, E.N.12
Tamargo, J.L.13
Wann, S.14
Smith Jr., S.C.15
Jacobs, A.K.16
Adams, C.D.17
Anderson, J.L.18
Antman, E.M.19
Halperin, J.L.20
Hunt, S.A.21
Nishimura, R.22
Ornato, J.P.23
Page, R.L.24
Riegel, B.25
Priori, S.G.26
Blanc, J.J.27
Budaj, A.28
Camm, A.J.29
Dean, V.30
Deckers, J.W.31
Despres, C.32
Dickstein, K.33
Lekakis, J.34
McGregor, K.35
Metra, M.36
Morais, J.37
Osterspey, A.38
Tamargo, J.L.39
Zamorano, J.L.40
more..
-
22
-
-
80052296951
-
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
-
Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH, Ritz E. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011;80:572-586.
-
(2011)
Kidney Int.
, vol.80
, pp. 572-586
-
-
Herzog, C.A.1
Asinger, R.W.2
Berger, A.K.3
Charytan, D.M.4
Díez, J.5
Hart, R.G.6
Eckardt, K.U.7
Kasiske, B.L.8
McCullough, P.A.9
Passman, R.S.10
DeLoach, S.S.11
Pun, P.H.12
Ritz, E.13
-
23
-
-
84858595913
-
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: Recommendations for stroke prevention and rate/rhythm control
-
Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee
-
Skanes AC, Healey JS, Cairns JA, Dorian P, Gillis AM, McMurtry MS, Mitchell LB, Verma A, Nattel S; Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol. 2012;28:125-136.
-
(2012)
Can J Cardiol.
, vol.28
, pp. 125-136
-
-
Skanes, A.C.1
Healey, J.S.2
Cairns, J.A.3
Dorian, P.4
Gillis, A.M.5
McMurtry, M.S.6
Mitchell, L.B.7
Verma, A.8
Nattel, S.9
-
24
-
-
84860715549
-
Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation
-
Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Behlouli H, Pilote L. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA. 2012;307:1952-1958.
-
(2012)
JAMA
, vol.307
, pp. 1952-1958
-
-
Avgil Tsadok, M.1
Jackevicius, C.A.2
Rahme, E.3
Humphries, K.H.4
Behlouli, H.5
Pilote, L.6
-
25
-
-
84884591124
-
Temporal trends in medication use and outcomes in atrial fibrillation
-
Pilote L, Eisenberg MJ, Essebag V, Tu JV, Humphries KH, Leung Yinko SS, Behlouli H, Guo H, Jackevicius CA. Temporal trends in medication use and outcomes in atrial fibrillation. Can J Cardiol. 2013;29:1241-1248.
-
(2013)
Can J Cardiol.
, vol.29
, pp. 1241-1248
-
-
Pilote, L.1
Eisenberg, M.J.2
Essebag, V.3
Tu, J.V.4
Humphries, K.H.5
Leung Yinko, S.S.6
Behlouli, H.7
Guo, H.8
Jackevicius, C.A.9
-
27
-
-
0031928630
-
Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: Effect of modifier codes
-
Goldstein LB. Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke. 1998;29:1602-1604.
-
(1998)
Stroke
, vol.29
, pp. 1602-1604
-
-
Goldstein, L.B.1
-
28
-
-
33750566282
-
Quality of diagnosis and procedure coding in ICD-10 administrative data
-
Henderson T, Shepheard J, Sundararajan V. Quality of diagnosis and procedure coding in ICD-10 administrative data. Med Care. 2006;44:1011-1019.
-
(2006)
Med Care.
, vol.44
, pp. 1011-1019
-
-
Henderson, T.1
Shepheard, J.2
Sundararajan, V.3
-
30
-
-
0033029198
-
Validity of stroke diagnosis on hospital discharge records in Saskatchewan, Canada: Implications for stroke surveillance
-
Liu L, Reeder B, Shuaib A, Mazagri R. Validity of stroke diagnosis on hospital discharge records in Saskatchewan, Canada: implications for stroke surveillance. Cerebrovasc Dis. 1999;9:224-230.
-
(1999)
Cerebrovasc Dis.
, vol.9
, pp. 224-230
-
-
Liu, L.1
Reeder, B.2
Shuaib, A.3
Mazagri, R.4
-
31
-
-
33847131371
-
Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients
-
Jackevicius CA, Paterson JM, Naglie G. Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients. Pharmacoepidemiol Drug Saf. 2007;16:207-215.
-
(2007)
Pharmacoepidemiol Drug Saf.
, vol.16
, pp. 207-215
-
-
Jackevicius, C.A.1
Paterson, J.M.2
Naglie, G.3
-
32
-
-
0038397012
-
Coding accuracy of administrative drug claims in the Ontario Drug Benefit database
-
Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10:67-71.
-
(2003)
Can J Clin Pharmacol.
, vol.10
, pp. 67-71
-
-
Levy, A.R.1
O'Brien, B.J.2
Sellors, C.3
Grootendorst, P.4
Willison, D.5
-
33
-
-
0029061011
-
The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Québec
-
Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec. J Clin Epidemiol. 1995;48:999-1009.
-
(1995)
J Clin Epidemiol.
, vol.48
, pp. 999-1009
-
-
Tamblyn, R.1
Lavoie, G.2
Petrella, L.3
Monette, J.4
-
34
-
-
27744473507
-
Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: A comparison of methods
-
Zhou Z, Rahme E, Abrahamowicz M, Pilote L. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. Am J Epidemiol. 2005;162:1016-1023.
-
(2005)
Am J Epidemiol.
, vol.162
, pp. 1016-1023
-
-
Zhou, Z.1
Rahme, E.2
Abrahamowicz, M.3
Pilote, L.4
-
35
-
-
0035854054
-
Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation
-
Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285: 2864-2870.
-
(2001)
JAMA
, vol.285
, pp. 2864-2870
-
-
Gage, B.F.1
Waterman, A.D.2
Shannon, W.3
Boechler, M.4
Rich, M.W.5
Radford, M.J.6
-
36
-
-
84861725443
-
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study
-
Friberg L, Rosenqvist M, Lip G Y. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33:1500-1510.
-
(2012)
Eur Heart J.
, vol.33
, pp. 1500-1510
-
-
Friberg, L.1
Rosenqvist, M.2
Lip, G.Y.3
-
37
-
-
79959323975
-
Bleeding risk in 'real world' patients with atrial fibrillation: Comparison of two established bleeding prediction schemes in a nationwide cohort
-
Olesen JB, Lip G Y, Hansen PR, Lindhardsen J, Ahlehoff O, Andersson C, Weeke P, Hansen ML, Gislason GH, Torp-Pedersen C. Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort. J Thromb Haemost. 2011;9:1460-1467.
-
(2011)
J Thromb Haemost.
, vol.9
, pp. 1460-1467
-
-
Olesen, J.B.1
Lip, G.Y.2
Hansen, P.R.3
Lindhardsen, J.4
Ahlehoff, O.5
Andersson, C.6
Weeke, P.7
Hansen, M.L.8
Gislason, G.H.9
Torp-Pedersen, C.10
-
38
-
-
0026492539
-
Intention-to-treat analysis: Implications for quantitative and qualitative research
-
Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. Int J Epidemiol. 1992;21:837-841.
-
(1992)
Int J Epidemiol.
, vol.21
, pp. 837-841
-
-
Newell, D.J.1
-
39
-
-
34247629651
-
Propensity scores in cardiovascular research
-
D'Agostino RB Jr. Propensity scores in cardiovascular research. Circulation. 2007;115:2340-2343.
-
(2007)
Circulation
, vol.115
, pp. 2340-2343
-
-
D'Agostino Jr., R.B.1
-
40
-
-
0041626110
-
Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders
-
Cepeda MS, Boston R, Farrar JT, Strom BL. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol. 2003;158:280-287.
-
(2003)
Am J Epidemiol.
, vol.158
, pp. 280-287
-
-
Cepeda, M.S.1
Boston, R.2
Farrar, J.T.3
Strom, B.L.4
-
41
-
-
84948773232
-
Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis
-
Egger M, Davey Smith G, Altman DG, eds. London, UK: BMJ Publishing Group
-
Deeks JJ, Altman DG, Bradburn MJ. Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis. In: Egger M, Davey Smith G, Altman DG, eds. Systematic Reviews in Health Care. London, UK: BMJ Publishing Group; 2001:285-312.
-
(2001)
Systematic Reviews in Health Care
, pp. 285-312
-
-
Deeks, J.J.1
Altman, D.G.2
Bradburn, M.J.3
-
42
-
-
79952662118
-
Severe renal impairment and stroke prevention in atrial fibrillation: Implications for thromboprophylaxis and bleeding risk
-
Marinigh R, Lane DA, Lip GY. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. J Am Coll Cardiol. 2011;57:1339-1348.
-
(2011)
J Am Coll Cardiol.
, vol.57
, pp. 1339-1348
-
-
Marinigh, R.1
Lane, D.A.2
Lip, G.Y.3
-
43
-
-
84870044418
-
Atrial fibrillation and chronic kidney disease
-
author reply 2158-2159
-
Baumann M, Seifert CL, Poppert H. Atrial fibrillation and chronic kidney disease. N Engl J Med. 2012;367:2157-2158; author reply 2158-2159.
-
(2012)
N Engl J Med.
, vol.367
, pp. 2157-2158
-
-
Baumann, M.1
Seifert, C.L.2
Poppert, H.3
-
44
-
-
84870044418
-
Atrial fibrillation and chronic kidney disease
-
author reply 2158-2159
-
Schlieper G, Krüger T, Floege J. Atrial fibrillation and chronic kidney disease. N Engl J Med. 2012;367:2157; author reply 2158-2159.
-
(2012)
N Engl J Med.
, vol.367
, pp. 2157
-
-
Schlieper, G.1
Krüger, T.2
Floege, J.3
-
45
-
-
84870004957
-
Atrial fibrillation and chronic kidney disease
-
author reply 2158; author reply 2158-2159
-
Sood MM, Tangri N. Atrial fibrillation and chronic kidney disease. N Engl J Med. 2012;367:2158; author reply 2158; author reply 2158-2159.
-
(2012)
N Engl J Med.
, vol.367
, pp. 2158
-
-
Sood, M.M.1
Tangri, N.2
-
46
-
-
2442695245
-
What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models
-
Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004;66:411-421.
-
(2004)
Psychosom Med.
, vol.66
, pp. 411-421
-
-
Babyak, M.A.1
-
47
-
-
84863700850
-
Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation
-
Ionescu-Ittu R, Abrahamowicz M, Jackevicius CA, Essebag V, Eisenberg MJ, Wynant W, Richard H, Pilote L. Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med. 2012;172:997-1004.
-
(2012)
Arch Intern Med.
, vol.172
, pp. 997-1004
-
-
Ionescu-Ittu, R.1
Abrahamowicz, M.2
Jackevicius, C.A.3
Essebag, V.4
Eisenberg, M.J.5
Wynant, W.6
Richard, H.7
Pilote, L.8
-
48
-
-
34548356858
-
The impact of residual and unmeasured confounding in epidemiologic studies: A simulation study
-
Fewell Z, Davey Smith G, Sterne JA. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007;166:646-655.
-
(2007)
Am J Epidemiol.
, vol.166
, pp. 646-655
-
-
Fewell, Z.1
Davey Smith, G.2
Sterne, J.A.3
-
49
-
-
0030187757
-
Confounding by indication
-
Walker AM. Confounding by indication. Epidemiology. 1996;7:335-336.
-
(1996)
Epidemiology
, vol.7
, pp. 335-336
-
-
Walker, A.M.1
-
50
-
-
18044386330
-
Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding
-
Normand SL, Sykora K, Li P, Mamdani M, Rochon PA, Anderson GM. Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding. BMJ. 2005;330:1021-1023.
-
(2005)
BMJ
, vol.330
, pp. 1021-1023
-
-
Normand, S.L.1
Sykora, K.2
Li, P.3
Mamdani, M.4
Rochon, P.A.5
Anderson, G.M.6
|